Ken Griffin Lantheus Holdings, Inc. Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$58.87 - $83.05 $7.37 Million - $10.4 Million	-125,200 Reduced 64.97%	67,500 $5.42 Million
Q1 2024 May 15, 2024	BUY	$51.07 - $68.26 $2.33 Million - $3.11 Million	45,600 Added 31.0%	192,700 $12 Million
Q4 2023 Feb 14, 2024	SELL	$55.6 - $77.89 $7.83 Million - $11 Million	-140,900 Reduced 48.92%	147,100 $9.12 Million
Q3 2023 Nov 14, 2023	BUY	$60.27 - $90.75 $11.7 Million - $17.6 Million	194,300 Added 207.36%	288,000 $20 Million
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $4.42 Million - $5.34 Million	53,600 Added 133.67%	93,700 $7.86 Million
Q1 2023 May 15, 2023	SELL	$47.76 - $82.86 $6.85 Million - $11.9 Million	-143,500 Reduced 78.16%	40,100 $3.31 Million
Q4 2022 Feb 14, 2023	SELL	$48.76 - $77.67 $814,292 - $1.3 Million	-16,700 Reduced 8.34%	183,600 $9.36 Million
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $10 Million - $14.1 Million	162,900 Added 435.56%	200,300 $14.1 Million

495

67.2M

1.19M

829K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.56B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.